1
|
Nguyen TV, Do LTK, Lin Q, Nagahara M, Namula Z, Wittayarat M, Hirata M, Otoi T, Tanihara F. Programmed cell death-1-modified pig developed using electroporation-mediated gene editing for in vitro fertilized zygotes. In Vitro Cell Dev Biol Anim 2024; 60:716-724. [PMID: 38485817 DOI: 10.1007/s11626-024-00869-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Accepted: 01/10/2024] [Indexed: 08/03/2024]
Abstract
Programmed cell death-1 (PD-1) is an immunoinhibitory receptor required to suppress inappropriate immune responses such as autoimmunity. Immune checkpoint antibodies that augment the PD-1 pathway lead to immune-related adverse events (irAEs), organ non-specific side effects due to autoimmune activation in humans. In this study, we generated a PD-1 mutant pig using electroporation-mediated introduction of the CRISPR/Cas9 system into porcine zygotes to evaluate the PD-1 gene deficiency phenotype. We optimized the efficient guide RNAs (gRNAs) targeting PD-1 in zygotes and transferred electroporated embryos with the optimized gRNAs and Cas9 into recipient gilts. One recipient gilt became pregnant and gave birth to two piglets. Sequencing analysis revealed that both piglets were biallelic mutants. At 18 mo of age, one pig showed non-purulent arthritis of the left elbow/knee joint and oligozoospermia, presumably related to PD-1 modification. Although this study has a limitation because of the small number of cases, our phenotypic analysis of PD-1 modification in pigs will provide significant insight into human medicine and PD-1-deficient pigs can be beneficial models for studying human irAEs.
Collapse
Affiliation(s)
- Thanh-Van Nguyen
- Faculty of Bioscience and Bioindustry, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
- Faculty of Veterinary Medicine, Vietnam National University of Agriculture, Hanoi, 100000, Vietnam
| | - Lanh Thi Kim Do
- Faculty of Bioscience and Bioindustry, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
- Faculty of Veterinary Medicine, Vietnam National University of Agriculture, Hanoi, 100000, Vietnam
| | - Qingyi Lin
- Faculty of Bioscience and Bioindustry, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
- Bio-Innovation Research Center, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
| | - Megumi Nagahara
- Faculty of Bioscience and Bioindustry, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
- Bio-Innovation Research Center, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
| | - Zhao Namula
- Faculty of Bioscience and Bioindustry, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
- College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang, 524088, China
| | - Manita Wittayarat
- Faculty of Veterinary Science, Prince of Songkla University, Songkhla, 90110, Thailand
| | - Maki Hirata
- Faculty of Bioscience and Bioindustry, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
- Bio-Innovation Research Center, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
| | - Takeshige Otoi
- Faculty of Bioscience and Bioindustry, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
- Bio-Innovation Research Center, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan
| | - Fuminori Tanihara
- Faculty of Bioscience and Bioindustry, Tokushima University, Ishii, Myozai-Gun, Tokushima, 7793233, Japan.
- Center for Development of Advanced Medical Technology, Jichi Medical University, Shimotsuke, Tochigi, 3290498, Japan.
| |
Collapse
|
2
|
Vingender S, Dőri F, Schmidt P, Hermann P, Vaszilkó MT. Evaluation of the efficiency of hyaluronic acid, PRP and I-PRF intra-articular injections in the treatment of internal derangement of the temporomandibular joint: A prospective study. J Craniomaxillofac Surg 2023; 51:1-6. [PMID: 36740515 DOI: 10.1016/j.jcms.2023.01.017] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Revised: 10/13/2022] [Accepted: 01/26/2023] [Indexed: 01/30/2023] Open
Abstract
This study aimed to evaluate the clinical effects of hyaluronic acid (HA), platelet-rich plasma (PRP), and platelet-rich fibrin (I-PRF) injections in the internal derangement of the temporomandibular joint. Adult patients who had failed to respond to nonsurgical treatment were were included in the study. The patients were divided into three treatment groups according to the given substance: 1) HA administration three times in a row on a weekly basis, 2) a single dose of PRP, or 3) a single dose of I-PRF. Clinical assessment was performed preoperatively and 6 and 12 months after the treatment, including maximal mouth opening (MMO) and pain level (Visual Analog Scale). Low and high molecular weight (HAL, HAH) hyaluronic acid forms were also compared. 68 adult patients, with a total of 109 joints were included in the study. The mean age was 53 ± 16 years. The statistical analysis showed a significant improvement in MMO in the HA group (p < 0.01). The pain level significantly decreased in all treatment groups (pHA,PRP,I-PRF<0.01). Comparing HAL and HAH forms, no significant difference was found in the evaluation of MMO and VAS values. Within the limitations of the study it seems that due to the similar effects of HA and the autologous blood substances, the platelet concentrates should be preferred in the intra-articular treatment in order to reduce the risk of possible adverse effects.
Collapse
Affiliation(s)
- Szonja Vingender
- Semmelweis University, Department of Oro-Maxillofacial Surgery and Stomatology, 1085, Budapest, Maria St. 52, Hungary.
| | - Ferenc Dőri
- Semmelweis University, Department of Periodontology, 1085, Budapest, Szentkiralyi St. 47, Hungary
| | - Péter Schmidt
- Semmelweis University, Department of Prosthodontics, 1085, Budapest, Szentkiralyi st. 47., Hungary
| | - Péter Hermann
- Semmelweis University, Department of Prosthodontics, 1085, Budapest, Szentkiralyi st. 47., Hungary
| | - Mihály Tamás Vaszilkó
- Semmelweis University, Department of Oro-Maxillofacial Surgery and Stomatology, 1085, Budapest, Maria St. 52, Hungary
| |
Collapse
|
3
|
Talian I, Laputková G, Schwartzová V. Identification of crucial salivary proteins/genes and pathways involved in pathogenesis of temporomandibular disorders. OPEN CHEM 2022. [DOI: 10.1515/chem-2022-0249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
Abstract
Temporomandibular disorder (TMD) is a collective term for a group of conditions that lead to impairment of the function of the temporomandibular joint. The proteins/genes and signaling pathways associated with TMD are still poorly understood. The aim of this study was to identify key differentially expressed salivary proteins/genes (DEGs) associated with TMD progression using LC-MS/MS coupled with a bioinformatics approach. The protein–protein interaction network was obtained from the STRING database and the hub genes were identified using Cytoscape including cytoHubba and MCODE plug-ins. In addition, enrichment of gene ontology functions and the Reactome signaling pathway was performed. A total of 140 proteins/genes were differentially expressed. From cluster analysis, a set of 20 hub genes were significantly modulated: ALB, APOA1, B2M, C3, CAT, CLU, CTSD, ENO1, GSN, HBB, HP, HSPA8, LTF, LYZ, MMP9, S100A9, SERPINA1, TF, TPI1, and TXN. Two enriched signaling pathways, glycolysis and gluconeogenesis, and tryptophan signaling pathway involving the hub genes CAT, ENO1, and TPI1 have been identified. The rest of the hub genes were mainly enriched in the innate immune system and antimicrobial peptides signaling pathways. In summary, hub DEGs and the signaling pathways identified here have elucidated the molecular mechanisms of TMD pathogenesis.
Collapse
Affiliation(s)
- Ivan Talian
- Department of Medical and Clinical Biophysics, Faculty of Medicine, University of P. J. Šafárik , Košice , 040 11 , Slovak Republic
| | - Galina Laputková
- Department of Medical and Clinical Biophysics, Faculty of Medicine, University of P. J. Šafárik , Košice , 040 11 , Slovak Republic
| | - Vladimíra Schwartzová
- Clinic of Stomatology and Maxillofacial Surgery, Faculty of Medicine, University of P. J. Šafárik and Louis Pasteur University Hospital , Košice , 041 90 , Slovak Republic
| |
Collapse
|
4
|
Moeda F, Melo X, Hatia M, Pinho S, Calado D, Branco JC, Gonçalves MJ. The Effects of Intra-Articular Platelet-Rich Plasma Injections in Rheumatoid Arthritis: A Narrative Review. Cureus 2022; 14:e28182. [PMID: 36148189 PMCID: PMC9482810 DOI: 10.7759/cureus.28182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/19/2022] [Indexed: 11/17/2022] Open
Abstract
Platelet-rich plasma injections have been a therapeutic option with exponential growth in several pathologies in the last decades, particularly musculoskeletal for their effect on improving pain and functionality. Rheumatoid arthritis is a chronic joint disease, which involves inflammation of the synovial membrane with cartilage and juxta-articular bone destruction. Conventional and biological disease-modifying anti-rheumatoid drugs are the cornerstone of the treatment of this disease. However, the use of intra-articular glucocorticoids is often necessary and the role of platelet-rich plasma injections in these patients remains uncertain. A literature review was carried out through the PubMed database, Cochrane and Google Scholar for the search terms “rheumatoid arthritis” and “platelet-rich plasma”. Eleven studies have been included in this review: two of these are in vitro studies, five are animal studies, one case report, two case series and one randomized controlled trial. Most of the studies demonstrated a decrease in pain and inflammatory mediators and improvement of functional outcomes, with no severe adverse effects reported. However, the quantity and quality of literature about the effects and safety of plasma-rich plasma injections in rheumatoid arthritis patients are still scarce. It is essential that well-designed randomized controlled trials are made on this topic to understand if platelet-rich plasma may be useful as a coadjuvant therapy in rheumatoid arthritis.
Collapse
|
5
|
Schmidt C, Reich R, Koos B, Ertel T, Ahlers MO, Arbogast M, Feurer I, Habermann-Krebs M, Hilgenfeld T, Hirsch C, Hügle B, von Kalle T, Kleinheinz J, Kolk A, Ottl P, Pautke C, Riechmann M, Schön A, Skroch L, Teschke M, Wuest W, Neff A. Controversial Aspects of Diagnostics and Therapy of Arthritis of the Temporomandibular Joint in Rheumatoid and Juvenile Idiopathic Arthritis-An Analysis of Evidence- and Consensus-Based Recommendations Based on an Interdisciplinary Guideline Project. J Clin Med 2022; 11:jcm11071761. [PMID: 35407368 PMCID: PMC8999183 DOI: 10.3390/jcm11071761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2022] [Revised: 03/18/2022] [Accepted: 03/19/2022] [Indexed: 01/27/2023] Open
Abstract
Introduction: Due to potentially severe sequelae (impaired growth, condylar resorption, and ankylosis) early diagnosis of chronic rheumatic arthritis of the temporomandibular joint (TMJ) and timely onset of therapy are essential. Aim: Owing to very limited evidence the aim of the study was to identify and discuss controversial topics in the guideline development to promote further focused research. Methods: Through a systematic literature search, 394 out of 3771 publications were included in a German interdisciplinary guideline draft. Two workgroups (1: oral and maxillofacial surgery, 2: interdisciplinary) voted on 77 recommendations/statements, in 2 independent anonymized and blinded consensus phases (Delphi process). Results: The voting results were relatively homogenous, except for a greater proportion of abstentions amongst the interdisciplinary group (p < 0.001). Eighty-four percent of recommendations/statements were approved in the first round, 89% with strong consensus. Fourteen recommendations/statements (18.2%) required a prolonged consensus phase and further discussion. Discussion: Contrast-enhanced MRI was confirmed as the method of choice for the diagnosis of TMJ arthritis. Intraarticular corticosteroid injection is to be limited to therapy-refractory cases and single injection only. In adults, alloplastic joint replacement is preferable to autologous replacement. In children/adolescents, autologous reconstruction may be performed lacking viable alternatives. Alloplastic options are currently still considered experimental.
Collapse
Affiliation(s)
- Christopher Schmidt
- Department of Oral and Craniomaxillofacial Surgery, UKGM GmbH, University Hospital Marburg, Faculty of Medicine, Philipps University, 35043 Marburg, Germany; (C.S.); (T.E.); (M.R.); (L.S.)
| | - Rudolf Reich
- Practice for Oral and Maxillofacial Plastic Surgery MVZ R(h)einZahn, 53111 Bonn, Germany;
| | - Bernd Koos
- Department of Orthodontics, University Hospital Tübingen, Eberhard Karls University Tübingen, 72074 Tübingen, Germany;
| | - Taila Ertel
- Department of Oral and Craniomaxillofacial Surgery, UKGM GmbH, University Hospital Marburg, Faculty of Medicine, Philipps University, 35043 Marburg, Germany; (C.S.); (T.E.); (M.R.); (L.S.)
- Medical Clinic, Hospital of Winsen, 21423 Winsen (Luhe), Germany
| | - Marcus Oliver Ahlers
- Department of Prosthetic Dentistry, Center for Dental and Oral Medicine, University Hospital Hamburg-Eppendorf, University of Hamburg, 20146 Hamburg, Germany;
- CMD-Center Hamburg-Eppendorf, 20251 Hamburg, Germany
| | - Martin Arbogast
- Department of Rheumatic Orthopedics and Hand Surgery, Hospital Oberammergau, 82487 Oberammergau, Germany;
| | - Ima Feurer
- Physiotherapeutic Practice & Orthopedic Manual Therapy, 78315 Radolfzell-Böhringen, Germany;
| | - Mario Habermann-Krebs
- Deutsche Rheuma-Liga Bundesverband e.V. (German Patients’ Association for Rheumatic Disorders), 53111 Bonn, Germany;
| | - Tim Hilgenfeld
- Department of Neuroradiology, University Hospital Heidelberg, Ruprecht-Karls-University Heidelberg, 69120 Heidelberg, Germany;
| | - Christian Hirsch
- Clinic of Pediatric Dentistry, University Hospital Leipzig, University of Leipzig, 04103 Leipzig, Germany;
| | - Boris Hügle
- German Centre for Pediatric Rheumatology, Childrens’ Hospital Garmisch-Partenkirchen, 82467 Garmisch-Partenkirchen, Germany;
| | - Thekla von Kalle
- Department of Pediatric Radiology, Olgahospital, Klinikum Stuttgart, 70174 Stuttgart, Germany;
| | - Johannes Kleinheinz
- Department of Cranio-Maxillofacial Surgery, University Hospital Münster, 48169 Münster, Germany;
| | - Andreas Kolk
- Department of Oral and Craniomaxillofacial Surgery, University Hospital Innsbruck, Leopold-Franzens-University Innsbruck, 6020 Innsbruck, Austria;
| | - Peter Ottl
- Department of Prosthodontic Dentistry, University Hospital Rostock, University of Rostock, 18057 Rostock, Germany;
| | - Christoph Pautke
- Medical Practice & Clinic for Oral and Maxillofacial Surgery, 80333 Munich, Germany;
| | - Merle Riechmann
- Department of Oral and Craniomaxillofacial Surgery, UKGM GmbH, University Hospital Marburg, Faculty of Medicine, Philipps University, 35043 Marburg, Germany; (C.S.); (T.E.); (M.R.); (L.S.)
| | - Andreas Schön
- Medical Practice & Clinic for Oral and Maxillofacial Surgery, 53842 Troisdorf, Germany;
| | - Linda Skroch
- Department of Oral and Craniomaxillofacial Surgery, UKGM GmbH, University Hospital Marburg, Faculty of Medicine, Philipps University, 35043 Marburg, Germany; (C.S.); (T.E.); (M.R.); (L.S.)
| | - Marcus Teschke
- Medical Practice for Oral and Craniomaxillofacial Surgery, 61352 Bad Homburg, Germany;
- Children’s Hospital Wilhelmstift, 22149 Hamburg, Germany
| | - Wolfgang Wuest
- Department of Radiology, Hospital Martha Maria Nürnberg, 90491 Nuremberg, Germany;
| | - Andreas Neff
- Department of Oral and Craniomaxillofacial Surgery, UKGM GmbH, University Hospital Marburg, Faculty of Medicine, Philipps University, 35043 Marburg, Germany; (C.S.); (T.E.); (M.R.); (L.S.)
- Correspondence:
| |
Collapse
|